Patents by Inventor Joffre Baker

Joffre Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
    Publication number: 20240096451
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Application
    Filed: August 23, 2023
    Publication date: March 21, 2024
    Applicant: Genomic Health, Inc.
    Inventors: Wayne Cowens, Steven SHAK, Audrey GODDARD, Dejan KNEZEVIC, Joffre Baker, Michael C. Kiefer, Tara MADDALA, Frederick L. Baehner
  • Method to use gene expression to determine likelihood of clinical outcome of renal cancer
    Patent number: 11776664
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: October 3, 2023
    Assignee: Genomic Health, Inc.
    Inventors: Wayne Cowens, Steven Shak, Audrey Goddard, Dejan Knezevic, Joffre Baker, Michael C. Kiefer, Tara Maddala, Frederick L. Baehner
  • Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
    Publication number: 20220051755
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Application
    Filed: November 19, 2020
    Publication date: February 17, 2022
    Applicant: Genomic Health, Inc.
    Inventors: Wayne COWENS, Steven SHAK, Audrey GODDARD, Dejan KNEZEVIC, Joffre BAKER, Michael C. KIEFER, Tara MADDALA, Frederick L. BAEHNER
  • Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer
    Publication number: 20210166790
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Application
    Filed: November 19, 2020
    Publication date: June 3, 2021
    Applicant: Genomic Health, Inc.
    Inventors: Wayne COWENS, Steven SHAK, Audrey GODDARD, Dejan KNEZEVIC, Joffre BAKER, Michael C. KIEFER, Tara MADDALA, Frederick L. BAEHNER
  • Method to use gene expression to determine likelihood of clinical outcome of renal cancer
    Patent number: 10892038
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: January 12, 2021
    Assignee: Genomic Health, Inc.
    Inventors: Wayne Cowens, Steven Shak, Audrey Goddard, Dejan Knezevic, Joffre Baker, Michael C. Kiefer, Tara Maddala, Frederick L. Baehner
  • METHOD TO USE GENE EXPRESSION TO DETERMINE LIKELIHOOD OF CLINICAL OUTCOME OF RENAL CANCER
    Publication number: 20170121780
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Application
    Filed: December 5, 2016
    Publication date: May 4, 2017
    Applicant: GENOMIC HEALTH, INC.
    Inventors: Wayne COWENS, Steven SHAK, Audrey GODDARD, Dejan KNEZEVIC, Joffre BAKER, Michael C. KIEFER, Tara MADDALA, Frederick L. BAEHNER
  • Method to use gene expression to determine likelihood of clinical outcome of renal cancer
    Patent number: 9551034
    Abstract: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
    Type: Grant
    Filed: January 7, 2011
    Date of Patent: January 24, 2017
    Assignee: Genomic Health, Inc.
    Inventors: Wayne Cowens, Steven Shak, Audrey Goddard, Dejan Knezevic, Joffre Baker, Michael C. Kiefer, Tara Maddala, Frederick L. Baehner
  • Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy
    Publication number: 20110171641
    Abstract: The present invention relates to genes, the expression levels of which are correlated with likelihood of breast cancer recurrence in patients after tumor resection and chemotherapy.
    Type: Application
    Filed: October 7, 2010
    Publication date: July 14, 2011
    Inventors: JOFFRE BAKER, ROBERT GRAY, STEVEN SHAK, JOSEPH SPARANO, CARL YOSHIZAWA
  • Gene expression markers for prediction of patient response to chemotherapy
    Publication number: 20090258795
    Abstract: A method of predicting clinical outcome in a subject diagnosed with cancer and treated with chemotherapy comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample comprising cancer cells obtained from the subject.
    Type: Application
    Filed: March 14, 2008
    Publication date: October 15, 2009
    Applicants: GENOMIC HEALTH, INC., NSABP FOUNDATION, INC.
    Inventors: Wayne Cowens, Joffre Baker, Kim Langone, Drew Watson, James Hackett, Soonmyung Paik
  • GENE EXPRESSION MARKERS OF RECURRENCE RISK IN CANCER PATIENTS AFTER CHEMOTHERAPY
    Publication number: 20090125247
    Abstract: The present invention relates to genes, the expression levels of which are correlated with likelihood of breast cancer recurrence in patients after tumor resection and chemotherapy.
    Type: Application
    Filed: August 15, 2008
    Publication date: May 14, 2009
    Inventors: JOFFRE BAKER, Robert Gray, Steven Shak, Joseph Sparano, Carl Yoshizawa
  • Gene Expression Markers for Response to EGFR Inhibitor Drugs
    Publication number: 20080176229
    Abstract: The present invention concerns prognostic markers associated with cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed samples of cancer tissue, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
    Type: Application
    Filed: May 30, 2007
    Publication date: July 24, 2008
    Inventors: David Agus, Steven Shak, Maureen Cronin, Joffre Baker
  • Genes involved estrogen metabolism
    Publication number: 20070275398
    Abstract: The invention concerns genes that have been identified as being involved in estrogen metabolism, and are useful as diagnostic, prognostic and/or predictive markers in cancer. In particular, the invention concerns genes the tumor expression levels of which are useful in the diagnosis of cancers associated with estrogen metabolism, and/or in the prognosis of clinical outcome and/or prediction of drug response of such cancers.
    Type: Application
    Filed: March 30, 2007
    Publication date: November 29, 2007
    Inventors: Michael Kiefer, Joffre Baker, James Hackett
  • Gene expression profiling in biopsied tumor tissues
    Publication number: 20070141588
    Abstract: The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. The invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
    Type: Application
    Filed: June 9, 2006
    Publication date: June 21, 2007
    Inventors: Joffre Baker, Maureen Cronin, Michael Kiefer, Steve Shak, Michael Walker
  • Gene expression profiling in biopsied tumor tissues
    Publication number: 20070141589
    Abstract: The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. The invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
    Type: Application
    Filed: June 9, 2006
    Publication date: June 21, 2007
    Inventors: Joffre Baker, Maureen Cronin, Michael Kiefer, Steve Shak, Michael Walker
  • Gene expression profiling in biopsied tumor tissues
    Publication number: 20070141587
    Abstract: The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. The invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
    Type: Application
    Filed: June 9, 2006
    Publication date: June 21, 2007
    Inventors: Joffre Baker, Maureen Cronin, Michael Kiefer, Steve Shak, Michael Walker
  • Predictors Of Patient Response To Treatment With EGFR Inhibitors
    Publication number: 20070128636
    Abstract: The invention concerns genes and gene sets and methods useful in the prediction of the response of a cancer patient to treatment with an epidermal growth factor receptor (EGFR) inhibitor.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 7, 2007
    Inventors: Joffre Baker, Michael Kiefer
  • Gene expression profiling in biopsied tumor tissues
    Publication number: 20070065845
    Abstract: The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. Th invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
    Type: Application
    Filed: June 9, 2006
    Publication date: March 22, 2007
    Inventors: Joffre Baker, Maureen Cronin, Michael Kiefer, Steve Shak, Michael Walker
  • Gene expression profiling in biopsied tumor tissues
    Publication number: 20070065846
    Abstract: The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. Th invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
    Type: Application
    Filed: June 9, 2006
    Publication date: March 22, 2007
    Inventors: Joffre Baker, Maureen Cronin, Michael Kiefer, Steve Shak, Michael Walker
  • Gene expression profiling in biopsied tumor tissues
    Publication number: 20070059737
    Abstract: The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. Th invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
    Type: Application
    Filed: June 9, 2006
    Publication date: March 15, 2007
    Inventors: Joffre Baker, Maureen Cronin, Michael Kiefer, Steve Shak, Michael Walker
  • Prediction of likelihood of cancer recurrence
    Publication number: 20060286565
    Abstract: The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of cancer, in particular of breast cancer.
    Type: Application
    Filed: January 31, 2006
    Publication date: December 21, 2006
    Inventors: Joffre Baker, John Bryant, Soonmyung Paik, Steven Shak